Targeting
EGFR
KRAS
MAPK
cancer
mutations
targeted-therapy
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
10 Mar 2021
10 Mar 2021
Historique:
received:
24
02
2021
accepted:
05
03
2021
entrez:
3
4
2021
pubmed:
4
4
2021
medline:
4
4
2021
Statut:
epublish
Résumé
The Kirsten rat sarcoma viral oncogene homolog (
Identifiants
pubmed: 33801965
pii: cancers13061204
doi: 10.3390/cancers13061204
pmc: PMC7999304
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : American Cancer Society
ID : Postdoctoral Fellowship 131779-PF-18-034-01-DMC
Organisme : Bolyai Janos fellowship of the Hungarian Academy of Sciences
ID : NKFIH-NNE-130913
Références
PLoS One. 2019 Apr 22;14(4):e0215504
pubmed: 31009485
Cell. 2017 Jun 29;170(1):17-33
pubmed: 28666118
Int J Gynecol Pathol. 1995 Jul;14(3):255-9
pubmed: 8600078
Anticancer Res. 2019 Feb;39(2):533-539
pubmed: 30711927
Mol Cancer Ther. 2015 Nov;14(11):2541-51
pubmed: 26304235
Mol Cancer Res. 2019 Apr;17(4):1002-1012
pubmed: 30635434
Oncogene. 2021 Jan;40(4):746-762
pubmed: 33247204
ACS Omega. 2019 Feb 28;4(2):2921-2930
pubmed: 30842983
Cancers (Basel). 2020 May 24;12(5):
pubmed: 32456277
J Exp Clin Cancer Res. 2018 Mar 13;37(1):57
pubmed: 29534749
PLoS One. 2016 Jun 13;11(6):e0157392
pubmed: 27295211
Blood. 2012 Oct 25;120(17):3397-406
pubmed: 22898602
Clin Cancer Res. 2009 Feb 15;15(4):1487-95
pubmed: 19228750
Leukemia. 2019 Aug;33(8):2111-2115
pubmed: 30872781
Cell Chem Biol. 2020 Sep 17;27(9):1151-1163.e6
pubmed: 32668202
Leukemia. 2018 Apr;32(4):931-940
pubmed: 28972594
Cell. 2018 Jan 25;172(3):578-589.e17
pubmed: 29373830
PLoS One. 2016 May 06;11(5):e0154967
pubmed: 27152724
Cancer Discov. 2011 Jun;1(1):35-43
pubmed: 22140652
Clin Colorectal Cancer. 2020 Dec;19(4):301-310.e1
pubmed: 32737004
Nature. 2020 Jan;577(7790):421-425
pubmed: 31915379
Front Oncol. 2019 Nov 12;9:1199
pubmed: 31781501
JAMA Oncol. 2017 Apr 1;3(4):516-522
pubmed: 27978579
J Biomed Sci. 2020 Jul 21;27(1):81
pubmed: 32690020
Lancet Oncol. 2013 Feb;14(2):134-40
pubmed: 23261356
Mol Cell Biol. 2006 Sep;26(17):6372-80
pubmed: 16914723
Curr Cancer Drug Targets. 2010 Mar;10(2):168-75
pubmed: 20088787
Oncotarget. 2017 Dec 21;9(5):6630-6643
pubmed: 29464099
Nature. 2000 Aug 17;406(6797):747-52
pubmed: 10963602
Oncogene. 2019 Mar;38(12):2005-2019
pubmed: 30467381
Ann Oncol. 2019 Feb 1;30(2):243-249
pubmed: 30462160
Ann Oncol. 2019 Oct 1;30(10):1671
pubmed: 31407004
Nat Med. 2019 Apr;25(4):620-627
pubmed: 30833748
Leukemia. 2020 Feb;34(2):625-629
pubmed: 31455850
Nat Rev Mol Cell Biol. 2008 Jul;9(7):517-31
pubmed: 18568040
J Clin Invest. 2014 Dec;124(12):5291-304
pubmed: 25384218
Oncogene. 2009 Mar 12;28(10):1385-92
pubmed: 19137007
Cancer Epidemiol Biomarkers Prev. 2017 Apr;26(4):444-457
pubmed: 28223433
Gynecol Oncol. 2015 Jul;138(1):30-5
pubmed: 25887099
EBioMedicine. 2019 Mar;41:711-716
pubmed: 30852159
Nature. 2015 Dec 10;528(7581):267-71
pubmed: 26633636
Prostate Cancer Prostatic Dis. 2019 Dec;22(4):531-538
pubmed: 30804427
Cancers (Basel). 2018 May 25;10(6):
pubmed: 29799479
Proc Natl Acad Sci U S A. 2013 May 14;110(20):8182-7
pubmed: 23630290
Nature. 2016 Jun 30;534(7609):647-51
pubmed: 27338794
Oncogene. 2016 Mar 10;35(10):1250-60
pubmed: 26028026
Cancer Discov. 2020 Jan;10(1):54-71
pubmed: 31658955
J Clin Oncol. 2009 Apr 20;27(12):2091-6
pubmed: 19188670
Cell. 2017 Feb 23;168(5):817-829.e15
pubmed: 28215705
Nature. 2020 Jun;582(7810):95-99
pubmed: 32494066
Cancer Res. 1993 Apr 15;53(8):1906-10
pubmed: 8467512
Cell. 2020 Nov 12;183(4):850-859
pubmed: 33065029
Oncotarget. 2017 Aug 2;8(39):66087-66097
pubmed: 29029494
Oncol Rep. 2017 Nov;38(5):3055-3063
pubmed: 29048617
Clin Cancer Res. 2009 Jul 15;15(14):4649-64
pubmed: 19567590
Cell Physiol Biochem. 2014;33(1):78-87
pubmed: 24480914
Nat Commun. 2016 Apr 20;7:11360
pubmed: 27094677
Br J Cancer. 2014 Mar 4;110(5):1148-54
pubmed: 24407191
Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10869-74
pubmed: 11553815
Anticancer Res. 1997 Sep-Oct;17(5A):3587-92
pubmed: 9413207
J Gynecol Oncol. 2018 Jan;29(1):e4
pubmed: 29185262
Oncogene. 2000 Nov 9;19(47):5338-47
pubmed: 11103935
Ann Oncol. 2016 Aug;27(8):1386-422
pubmed: 27380959
Cancer Discov. 2020 Aug 19;:
pubmed: 32816843
Front Mol Biosci. 2020 Jul 24;7:172
pubmed: 32850962
Clin Cancer Res. 2002 Jun;8(6):1747-53
pubmed: 12060612
Oncotarget. 2017 Apr 4;8(14):22443-22459
pubmed: 27705918
Clin Cancer Res. 2016 Mar 15;22(6):1499-509
pubmed: 26515496
Exp Dermatol. 2016 Nov;25(11):863-864
pubmed: 27193637
Int J Gynecol Pathol. 2012 May;31(3):195-205
pubmed: 22498935
Leukemia. 2011 Jul;25(7):1080-94
pubmed: 21494257
Pharmaceuticals (Basel). 2020 Nov 09;13(11):
pubmed: 33182254
PLoS One. 2014 Mar 26;9(3):e93451
pubmed: 24671188
Int J Gynecol Pathol. 2008 Apr;27(2):151-60
pubmed: 18317228
Mol Cancer. 2017 Jun 28;16(1):112
pubmed: 28659148
J Clin Oncol. 2008 Oct 1;26(28):4603-9
pubmed: 18559876
J Exp Clin Cancer Res. 2019 Sep 5;38(1):391
pubmed: 31488180
Nat Rev Drug Discov. 2019 Nov;18(12):887-891
pubmed: 31780856
Int J Gynecol Cancer. 2017 Jun;27(5):854-862
pubmed: 28498246
Nat Commun. 2015 Apr 27;6:6706
pubmed: 25913614
Mol Cancer Res. 2017 Jul;15(7):905-914
pubmed: 28242811
Ann Oncol. 2016 Apr;27 Suppl 1:i16-i19
pubmed: 27141064
Oncogene. 2018 Feb 15;37(7):897-911
pubmed: 29059159